A procedure for rating the potential of an individual for developing demonstrable coronary artery disease associated with VLDLC toxicity, comprising determining quantitatively from a sample of said individual's serum the level therein of each of the components PF and RF, calculating from these component levels the value of the ratio PF/RF, comparing this value with a rating standard for said potential.
ARTERIOSCLEROSIS PROGNOSTICATION PROCEDURE AND THERAPEUTIC METHOD